tiprankstipranks
Trending News
More News >
AbbVie (DE:4AB)
XETRA:4AB
Germany Market
Advertisement

AbbVie (4AB) Technical Analysis

Compare
24 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
14Bullish
6Neutral
2Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
AbbVie’s (4AB) Moving Averages Convergence Divergence (MACD) indicator is 3.91, suggesting AbbVie is a Sell.
AbbVie’s (4AB) 20-Day exponential moving average is 174.34, while AbbVie’s (4AB) share price is €179.2, making it a Buy.
AbbVie’s (4AB) 50-Day exponential moving average is 169.49, while AbbVie’s (4AB) share price is €179.2, making it a Buy.

AbbVie (4AB) Pivot Points

Aug 28, 2025, 10:29 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
176.27
176.93
177.47
178.13
178.67
179.33
179.87
Fibonacci
176.93
177.39
177.67
178.13
178.59
178.87
179.33
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbbVie (4AB) Moving Averages

Aug 28, 2025, 10:29 PM
Period
Simple
Exponential
MA5
179.32Sell
178.67Buy
MA10
178.26Buy
177.40Buy
MA20
174.04Buy
174.34Buy
MA50
166.25Buy
169.49Buy
MA100
163.87Buy
168.33Buy
MA200
169.26Buy
169.14Buy
AbbVie’s (4AB) 10-Day exponential moving average is 177.40, while AbbVie’s (4AB) share price is €179.2, making it a Buy.
AbbVie’s (4AB) 100-Day exponential moving average is 168.33, while AbbVie’s (4AB) share price is €179.2, making it a Buy.
AbbVie’s (4AB) stock price is €179.2 and AbbVie’s (4AB) 50-day simple moving average is 166.25, creating a Buy signal.
AbbVie’s (4AB) stock price is €179.2 and AbbVie’s (4AB) 100-day simple moving average is 163.87, creating a Buy signal.
AbbVie’s (4AB) stock price is €179.2 and AbbVie’s (4AB) 200-day simple moving average is 169.26, creating a Buy signal.

AbbVie (4AB) Technical Indicators

Aug 28, 2025, 10:29 PM
Name
Value
Implied Action
RSI (14)
63.96
Neutral
STOCH (9,6)
57.23
Neutral
STOCHRSI (14)
70.06
Neutral
MACD (12,26)
3.91
Sell
ADX (14)
31.78
Neutral
Williams %R
-26.09
Buy
CCI (14)
86.87
Neutral
ATR (14)
2.94
-
Ultimate Oscillator
49.95
Neutral
ROC
5.29
Buy
AbbVie’s (4AB) Relative Strength Index (RSI) is 63.96, creating a Neutral signal.
AbbVie’s (4AB) Trend Strength Indicator (ADX) is 31.78, creating a Neutral signal.
AbbVie’s (4AB) Commodity Channel Index (CCI) is 86.87, creating a Neutral signal.
AbbVie’s (4AB) Price Rate of Change (ROC) is 5.29, creating a Buy signal.

FAQ

Is 4AB a Buy, Hold, or Sell?
Based on 4AB’s technical indicators, 4AB is a Strong Buy.
    What is 4AB’s RSI (14)?
    4AB’s RSI (14) is 63.96, which suggests 4AB is a Neutral.
      What is 4AB’s MACD?
      4AB’s MACD is 3.91, which suggests 4AB is a Sell.
        What is 4AB’s 5-day moving average?
        4AB’s 5-day moving average is 179.32, which suggests 4AB is a Sell.
          What is 4AB’s 20-day moving average?
          4AB 20-day moving average is 174.04, which suggests 4AB is a Buy.
            What is 4AB’s 50-day moving average?
            4AB’s 50-day moving average is 166.25, which suggests 4AB is a Buy.
              What is 4AB’s 200-day moving average?
              4AB’s 200-day moving average is 169.26, which suggests 4AB is a Buy.
                What is 4AB’s Williams % R (14)?
                4AB’s Williams % R (14) is -26.09, which suggests 4AB is a Buy.
                  What is 4AB’s CCI (14)?
                  4AB’s CCI (14) is 86.87, which suggests 4AB is a Neutral.
                    What is the share price of AbbVie?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis